Related Experiment Videos

Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart

Soma S Nag1, Thomas A Pearson, Larry Ma

  • 1Outcomes Research and Management, Merck & Co., Inc., West Point, Pennsylvania, USA. soma_nag@merck.com

The American Journal of Cardiology
|March 23, 2005
PubMed

Insights

Many at-risk patients did not receive lipid-lowering therapy between 2000-2001. The study found a 62% treatment gap, highlighting a need for improved management of high cholesterol.

Area of Science:

  • Cardiovascular Medicine
  • Public Health

Background:

  • Cardiovascular disease remains a leading cause of mortality worldwide.
  • Effective management of dyslipidemia is crucial for primary and secondary prevention of cardiovascular events.
  • Identifying treatment gaps in lipid-lowering therapy is essential for improving patient outcomes.

Purpose of the Study:

  • To determine lipid-lowering therapy treatment rates in patients with multiple cardiovascular risk factors but without diagnosed coronary heart disease.
  • To estimate the treatment gap for lipid-lowering therapy in this high-risk population.

Main Methods:

  • Retrospective analysis of the Ingenix LabRx Database from 2000 to 2001.
  • Identification of patients with multiple risk factors (age, hypertension, low HDL, high total cholesterol, obesity) but no coronary heart disease.
  • Estimation of lipid treatment rates based on defined criteria for needing therapy (LDL-C >/=130 mg/dl or current therapy).

Main Results:

  • The overall lipid-lowering therapy treatment rate was 38%.
  • An estimated 62% of patients who needed lipid-lowering therapy were not receiving it.
  • This indicates a significant treatment gap in managing dyslipidemia in at-risk individuals.

Conclusions:

  • A substantial proportion of patients with multiple cardiovascular risk factors were undertreated with lipid-lowering therapy during the study period.
  • The findings underscore the need for enhanced strategies to improve the initiation and adherence to lipid-lowering treatments in high-risk populations.
  • Addressing this treatment gap is critical for reducing the burden of cardiovascular disease.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...